Brief: Arcticzymes Technologies Divests Biotec BetaGlucans Subsidiary To Lallemand

Arcticzymes Technologies ASA

14/12/2020 07:17

Dec 14 (Reuters) - Arcticzymes Technologies ASA  ARCZ.OL :
    * ARCTICZYMES TECHNOLOGIES DIVESTS BIOTEC BETAGLUCANS
SUBSIDIARY
TO LALLEMAND
    * TRANSACTION IS BASED ON AN ENTERPRISE VALUE OF NOK 70
MILLION
PAYABLE IN CASH AT CLOSING
    * CLOSING EXPECTED END OF DECEMBER 2020
    * UNDER TERMS OF SPA, LALLEMAND WILL ACQUIRE ALL OF BBG
ASSETS AND
ASSOCIATED INTELLECTUAL PROPERTY

Source text for Eikon:  ID:nWkrbwmMyC 
Further company coverage:  ARCZ.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))